Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Frank Essler has worked on the following 28 EPO patent applications which have been published in the last five years:

EP11725479

AZOLOPYRIDIN-3-ONE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES

IPC classification:
A61K 31/425, C07D 513/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP11806025

COMPOSITIONS COMPRISING A PI3K INHIBITOR AND A MEK INHIBITOR AND THEIR USE FOR TREATING CANCER

IPC classification:
A61K 31/44, A61K 31/498, A61K 31/519, A61P 35/00
Applicant:
Sanofi, S.A.
Applicant:
Merck Patent GmbH
Applicant:
Sanofi
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP12707762

BENZYL-OXATHIAZINE DERIVATES SUBSTITUTED WITH ADAMANTANE OR NORADAMANTANE, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/02
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP12707761

NOVEL SUBSTITUTED PHENYL-OXATHIAZINE DERIVATIVES, METHOD FOR PRODUCING THEM, DRUGS CONTAINING SAID COMPOUNDS AND THE USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/06, C07D 419/10
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707597

OXATHIAZINE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL OR HETEROMETHYLENE GROUPS, METHOD FOR PRODUCING THEM, THEIR USE AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND THE USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/06, C07D 419/10, C07D 419/14
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707596

TETRASUBSTITUTED OXATHIAZINE DERIVATIVES, METHOD FOR PRODUCING THEM, THEIR USE AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND THE USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/02, C07D 291/06, C07D 419/12, C07D 515/10
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707340

DI- AND TRI-SUBSTITUTED OXATHIAZINE DERIVATES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND USE THEREOF

IPC classification:
A61K 31/54, A61P 31/00, C07D 291/08
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707339

BRANCHED OXATHIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/08
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12708011

NOVEL SUBSTITUTED PHENYL-OXATHIAZINE DERIVATIVES, METHOD FOR PRODUCING THEM, DRUGS CONTAINING SAID COMPOUNDS AND THE USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/06, C07D 419/04, C07D 419/10
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707341

DI- AND TRI-SUBSTITUTED OXATHIAZINE DERIVATES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/06, C07D 291/08, C07D 419/12
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12733130

CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[4,5-C]PYRIDINE RING

IPC classification:
A61K 31/424, C07D 498/04
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP12733131

CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-B]PYRIDINE RING

IPC classification:
A61K 31/437, C07D 498/04
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12708536

OXATHIAZINE DERIVATIVES SUBSTITUTED WITH CARBOCYCLES OR HETEROCYCLES, METHOD FOR PRODUCING SAME, DRUGS CONTAINING SAID COMPOUNDS, AND USE THEREOF

IPC classification:
A61K 31/54, A61P 3/10, C07D 291/08, C07D 515/04
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12738474

SUBSTITUTED 3 - (THIAZOLE - 4 - CARBONYL) - OR 3 - (THIAZOLE - 2 - CARBONYL) AMINOPROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/426, A61K 31/427, A61P 9/00, A61P 9/10, A61P 9/12, A61P 11/00, A61P 13/00, C07D 277/54, C07D 417/04
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13700260

3-[4-(PHENYLAMINOOXALYLAMINO)PHENYL]HEX-4-YNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

IPC classification:
A61K 31/165, A61P 3/08, A61P 3/10, C07C 231/02, C07C 233/56
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP12735503

CARBOXYLIC ACID DERIVATIVES WITH AN OXAZOLO[4,5-C]PYRIDINE RING

IPC classification:
A61K 31/52, A61P 9/04, A61P 43/00, C07D 498/04
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12732677

CARBOXYLIC ACID DERIVATIVES WITH AN OXAZOLO[5,4-D]PYRIMIDINE RING

IPC classification:
A61K 31/519, A61P 9/04, A61P 43/00, C07D 498/04
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14187399

Intermediates for the synthesis of oxygen-substituted 3-heteroaroylamino-propionic acid derivatives

IPC classification:
A61K 31/415, A61P 37/00, C07C 229/34, C07C 229/36, C07D 231/20, C07D 231/22, C07D 401/04, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12, C07D 417/12
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP13763087

BENZOIMIDAZOLE-CARBOXYLIC ACID AMIDE DERIVATIVES AS APJ RECEPTOR MODULATORS

IPC classification:
A61K 31/4184, A61P 3/10, A61P 9/10, C07D 235/08, C07D 403/06, C07D 405/06, C07D 409/14, C07D 411/06, C07D 413/14, C07D 417/06, C07D 451/04, C07D 487/06
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP13773793

PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

IPC classification:
A61K 31/4439, A61P 3/04, A61P 3/06, A61P 3/10, C07D 401/12, C07D 401/14, C07D 407/14, C07D 417/14
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP14712312

BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/426, A61P 9/00, A61P 11/08, A61P 19/02, A61P 23/00, C07D 263/32, C07D 271/10, C07D 277/30, C07D 413/10
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP14712667

BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/426, A61P 9/00, A61P 11/08, A61P 19/02, A61P 23/00, C07D 263/32, C07D 271/10, C07D 277/30, C07D 413/10
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP14306428

Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

IPC classification:
C07C 311/21, C07D 207/16, C07D 211/60, C07D 401/12
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP14306431

Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

IPC classification:
C07C 311/21, C07D 213/80, C07D 231/14, C07D 333/40
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP14306429

Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

IPC classification:
C07C 209/30, C07C 311/21, C07C 311/29, C07C 311/46, C07D 207/27, C07D 209/08, C07D 213/71, C07D 215/36, C07D 215/38, C07D 231/12, C07D 231/18, C07D 265/36, C07D 277/36, C07D 277/46, C07D 277/62, C07D 333/34, C07D 333/62
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP14306430

Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders

IPC classification:
A61K 31/18, A61P 3/10, C07C 311/21, C07D 207/16, C07D 211/60, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/12, C07D 405/14, C07D 409/12, C07D 409/14, C07D 417/12
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP12700866

AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/415, A61K 31/4155, A61K 31/4162, A61P 9/00, C07D 231/38, C07D 401/04, C07D 401/12, C07D 403/04, C07D 403/06, C07D 405/12, C07D 417/04, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12701126

SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/4439, A61P 11/00, C07D 213/81, C07D 213/82, C07D 217/22, C07D 401/04, C07D 401/12, C07D 405/12, C07D 413/04, C07D 471/04, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Frank Essler, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED

Please Sign in to use this feature